Volume | 243,885 |
|
|||||
News | (2) | ||||||
Day High | 25.9875 | Low High |
|||||
Day Low | 24.49 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Pharvaris NV | PHVS | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
25.42 | 24.49 | 25.9875 | 25.00 | 25.42 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
1,888 | 243,885 | $ 25.44 | $ 6,204,767 | - | 3.85 - 29.80 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
18:51:59 | 1 | $ 25.46 | USD |
Pharvaris NV Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
1.02B | 40.82M | - | 0 | -76.33M | -1.87 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Pharvaris NV News
Loading Messages....
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical PHVS Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 17.36 | 29.80 | 16.81 | 24.61 | 572,907 | 7.64 | 44.01% |
1 Month | 16.59 | 29.80 | 15.00 | 22.16 | 208,777 | 8.41 | 50.69% |
3 Months | 20.56 | 29.80 | 15.00 | 21.50 | 86,680 | 4.44 | 21.6% |
6 Months | 8.26 | 29.80 | 8.25 | 19.28 | 76,545 | 16.74 | 202.66% |
1 Year | 4.19 | 29.80 | 3.85 | 11.37 | 491,495 | 20.81 | 496.66% |
3 Years | 25.00 | 42.86 | 1.77 | 12.47 | 196,339 | 0.00 | 0.0% |
5 Years | 25.00 | 42.86 | 1.77 | 12.47 | 196,339 | 0.00 | 0.0% |
Pharvaris NV Description
Pharvaris NV is a clinical-stage company. It is focused on the discovery and development of novel oral bradykinin B2-receptor antagonists for the treatment of hereditary angioedema (HAE) and other bradykinin B2-receptor-mediated indications. |